Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v33-FR Version v8-EN
Language French English
Date Updated 2024-01-05 2022-11-04
Drug Identification Number 02415100 02415100
Brand name TARO-ZOLEDRONIC ACID TARO-ZOLEDRONIC ACID
Common or Proper name ZOLEDRONIC ZOLEDRONIC
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients ZOLEDRONIC ACID ZOLEDRONIC ACID
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 100 100
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-08-09 2022-08-09
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Recall with no back up inventory currently available Recall with no back up inventory currently available
Health Canada comments